Li I-Chen, Lee Li-Ya, Tzeng Tsai-Teng, Chen Wan-Ping, Chen Yen-Po, Shiao Young-Ju, Chen Chin-Chu
Grape King Bio Ltd, Zhong-Li Dist., Taoyuan City, Taiwan.
Institute of Biopharmaceutical Sciences, National Yang-Ming University, Taipei City, Taiwan.
Behav Neurol. 2018 May 21;2018:5802634. doi: 10.1155/2018/5802634. eCollection 2018.
, an ideal culinary-medicinal mushroom, has become a well-established candidate in promoting positive brain and nerve health-related activities by inducing the nerve growth factor from its bioactive ingredient. Among its active compounds, only erinacine A has confirmed pharmacological actions in the central nervous system in rats. Hence, this review has summarized the available information on the neurohealth properties of mycelia enriched with erinacines, which may contribute to further research on the therapeutic roles of these mycelia. The safety of this mushroom has also been discussed. Although it has been difficult to extrapolate the studies to clinical situations, preclinical studies have shown that there can be improvements in ischemic stroke, Parkinson's disease, Alzheimer's disease, and depression if mycelia enriched with erinacines are included in daily meals.
作为一种理想的食药两用蘑菇,通过其生物活性成分诱导神经生长因子,已成为促进积极的大脑和神经健康相关活动的成熟候选物。在其活性化合物中,只有erinacine A在大鼠中枢神经系统中具有已确认的药理作用。因此,本综述总结了富含erinacines的菌丝体的神经健康特性的现有信息,这可能有助于进一步研究这些菌丝体的治疗作用。还讨论了这种蘑菇的安全性。尽管将这些研究外推至临床情况存在困难,但临床前研究表明,如果在日常饮食中加入富含erinacines的菌丝体,缺血性中风、帕金森病、阿尔茨海默病和抑郁症可能会有所改善。